These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29300685)

  • 1. Development of novel vaccine vectors: Chimpanzee adenoviral vectors.
    Guo J; Mondal M; Zhou D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1679-1685. PubMed ID: 29300685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
    Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
    PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development.
    Luo S; Zhang P; Ma X; Wang Q; Lu J; Liu B; Zhao W; Allain JP; Li C; Li T
    Virus Res; 2019 Jul; 268():1-10. PubMed ID: 31108113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.
    Cheng C; Wang L; Ko SY; Kong WP; Schmidt SD; Gall JGD; Colloca S; Seder RA; Mascola JR; Nabel GJ
    Vaccine; 2015 Dec; 33(51):7344-7351. PubMed ID: 26514419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors.
    Iampietro MJ; Larocca RA; Provine NM; Abbink P; Kang ZH; Bricault CA; Barouch DH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.
    Vitelli A; Folgori A; Scarselli E; Colloca S; Capone S; Nicosia A
    Expert Rev Vaccines; 2017 Dec; 16(12):1241-1252. PubMed ID: 29047309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
    Zhou D; Zhou X; Bian A; Li H; Chen H; Small JC; Li Y; Giles-Davis W; Xiang Z; Ertl HCJ
    Nat Protoc; 2010 Nov; 5(11):1775-1785. PubMed ID: 21030953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
    Dudareva M; Andrews L; Gilbert SC; Bejon P; Marsh K; Mwacharo J; Kai O; Nicosia A; Hill AV
    Vaccine; 2009 Jun; 27(27):3501-4. PubMed ID: 19464527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral vector-based strategies against infectious disease and cancer.
    Zhang C; Zhou D
    Hum Vaccin Immunother; 2016 Aug; 12(8):2064-2074. PubMed ID: 27105067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
    Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
    J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Novel Adenovirus Vectors Mediated Differential Antibody Responses via Interferon-α and Natural Killer Cells.
    Zou P; Zhang P; Deng Q; Wang C; Luo S; Zhang L; Li C; Li T
    Microbiol Spectr; 2023 Aug; 11(4):e0088023. PubMed ID: 37347197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.
    Capone S; D'Alise AM; Ammendola V; Colloca S; Cortese R; Nicosia A; Folgori A
    Expert Rev Vaccines; 2013 Apr; 12(4):379-93. PubMed ID: 23560919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
    Green CA; Scarselli E; Sande CJ; Thompson AJ; de Lara CM; Taylor KS; Haworth K; Del Sorbo M; Angus B; Siani L; Di Marco S; Traboni C; Folgori A; Colloca S; Capone S; Vitelli A; Cortese R; Klenerman P; Nicosia A; Pollard AJ
    Sci Transl Med; 2015 Aug; 7(300):300ra126. PubMed ID: 26268313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus.
    Zhi Y; Figueredo J; Kobinger GP; Hagan H; Calcedo R; Miller JR; Gao G; Wilson JM
    Hum Gene Ther; 2006 May; 17(5):500-6. PubMed ID: 16716107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.
    Hartnell F; Brown A; Capone S; Kopycinski J; Bliss C; Makvandi-Nejad S; Swadling L; Ghaffari E; Cicconi P; Del Sorbo M; Sbrocchi R; Esposito I; Vassilev V; Marriott P; Gardiner CM; Bannan C; Bergin C; Hoffmann M; Turner B; Nicosia A; Folgori A; Hanke T; Barnes E; Dorrell L
    Front Immunol; 2018; 9():3175. PubMed ID: 30713538
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.
    Vitelli A; Quirion MR; Lo CY; Misplon JA; Grabowska AK; Pierantoni A; Ammendola V; Price GE; Soboleski MR; Cortese R; Colloca S; Nicosia A; Epstein SL
    PLoS One; 2013; 8(3):e55435. PubMed ID: 23536756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.
    Paris R; Kuschner RA; Binn L; Thomas SJ; Colloca S; Nicosia A; Cortese R; Bailer RT; Sullivan N; Koup RA
    Clin Vaccine Immunol; 2014 May; 21(5):783-6. PubMed ID: 24623627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an adenoviral vaccine vector based on simian adenovirus 21.
    Roy S; Zhi Y; Kobinger GP; Figueredo J; Calcedo R; Miller JR; Feldmann H; Wilson JM
    J Gen Virol; 2006 Sep; 87(Pt 9):2477-2485. PubMed ID: 16894185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.